Blood NAD+ levels and ageing
A 2022 cohort of 1,518 people reported that whole blood NAD+ content declines with age in males, with a significant drop in the 40 to 49 age group. Reported in the cited paper.
SourceResearch Use Only. Products listed are not for human or animal consumption. Statements have not been evaluated by the FDA.View full disclaimers →
The directory
83 listed
Newsletter · Quarterly
Get notified about new lab results, price drops and supplier coupons before everyone else.
We respect your privacy. No spam.
NAD+ is a coenzyme present in every cell, central to energy metabolism, DNA repair and sirtuin signalling. It is not a peptide. Supplemental forms include intravenous infusion, subcutaneous injection and oral precursors such as NMN and nicotinamide riboside.
Vendor listings
Show prices as
119 listings · NAD+
In stock100mgseen 4d ago
In stock100mgseen 4d ago
In stock100mgseen 4d ago
In stock500mgseen 3d ago
In stock500mgseen 3d ago
In stock500mgseen 5d ago
In stock500mgseen 3d ago
In stock500mgseen 6d ago
In stock500mgseen 4d ago
In stock100mgseen 4d ago
In stock500mgseen 5d ago
In stock500mgseen 5d ago
In stock500mgseen 7d ago
In stock500mgseen 4d ago
In stock500mgseen 4d ago
In stock500mgseen 6d ago
In stock500mgseen 6d ago
In stock500mgseen 6d ago
In stock1000mgseen 3d ago
In stock500mgseen 4d ago
Overview
NAD+ is a coenzyme present in every cell, central to energy metabolism, DNA repair and sirtuin signalling. It is not a peptide. Supplemental forms include intravenous infusion, subcutaneous injection and oral precursors such as NMN and nicotinamide riboside.
What the research reports
Outcomes described across the published NAD+ literature and ongoing study. Read each as research context rather than a promised personal result.
Cellular energy metabolism
Sits at the centre of mitochondrial energy production, acting as the electron carrier that drives ATP generation in every cell. Reported in research settings.
DNA repair pathway support
Serves as substrate for PARP enzymes involved in DNA repair, which is the mechanistic basis for most longevity interest. Reported in research settings.
Sirtuin activation dependency
Sirtuins depend on NAD+ as a cofactor, linking its availability to pathways associated with cellular ageing in laboratory work. Reported in research settings.
Age related NAD+ level decline
A cohort of 1,518 people found whole blood NAD+ declines with age in males, with a notable drop in the 40 to 49 group. Described in the research record.
Clinic based infusion use
Intravenous protocols have become common in wellness and longevity clinics, though controlled efficacy trials remain absent. Reported in research settings.
Dosage and protocol
Protocols use 250 to 1000 mg intravenously, 50 to 200 mg subcutaneously, or oral precursors at 250 to 1000 mg of NMN daily. Figures describe study protocols, not a personal regimen.
Clinical evidence
The published NAD+ record, labeled by strength so you can see what is settled and what is still emerging.
A 2022 cohort of 1,518 people reported that whole blood NAD+ content declines with age in males, with a significant drop in the 40 to 49 age group. Reported in the cited paper.
SourceA 2023 cohort of 169 healthy individuals assessed NAD+ alongside sirtuin 1, klotho and other markers, reporting variation by age and by sex. Reported in the cited paper.
SourceThe listed studies measure NAD+ as it varies naturally rather than testing supplementation, so clinical efficacy data remains preliminary. Reported in the cited paper.
SourceInteractions
Questions